Skip to content
buyModerate cluster of 3

Valerie Denise Harding Start bought $18k of ERAS

director at Erasca, Inc.. 10,000 shares at an average of $1.85, traded Dec 6, 2023, filed Dec 8, 2023.

Conviction score
58
Value
$18k
10,000 shares
Holdings after
20,000
+100% from before
From 52-week low
+4%
low $1.67, close $1.73
From 52-week high
-76%
high $7.31, as of Dec 6, 2023

Score components

  • Role
    Director
    +15
  • Trade size
    $18k at market
    0
  • Relative to holdings
    Holdings up 100%
    +10
  • Price context
    4% above the 52-week low; 76% below the 52-week high
    +18
  • Cluster
    3 insiders buying within 14 days
    +15
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +9.1%, 3m +21.9%, 6m +27.0%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ERASOct 13, 2026 · close 14.78
Since filing Dec 8, 2023: +690.4%SPY +75.3% · excess +615.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001209191-23-057833, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 6, 2023POpen-market purchase
Common Stockindirect: By Start 2006 Trust
+10,000$1.85$18k20,000Dec 8, 2023

Related signals

Other insiders at Erasca, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
25Weak
ERASsell10b5-1
Erasca, Inc.
Ebun Garner
Chief Legal Officer
$1.3M
80,000 shares
-76%
14Weak
ERASsell10b5-1
Erasca, Inc.
Shannon Morris
Chief Medical Officer
$301k
20,000 shares
-100%
20Weak
ERASsell10b5-1
Erasca, Inc.
Ebun Garner
General Counsel & Corp. Sec.
$671k
120,000 shares
-83%
34Weak
ERASbuy
Erasca, Inc.
Alexander W. Casdin
director
$182k
80,000 shares
+16%
86Strong
ERASbuy 3
Erasca, Inc.
Jonathan E Lim
Chairman & CEO
$1.7M
1,000,000 shares
+8%
58Moderate
ERASbuy 3
Erasca, Inc.
Alexander W. Casdin
director
$50k
30,000 shares
+6%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Valerie Denise Harding Start bought $18k of ERAS | InsiderTell